Blend Blend · one vial
KLOW
KPV + GHK-Cu + BPC-157 + TB-500
GLOW plus KPV, an anti-inflammatory α-MSH fragment.
Components: KPV + GHK-Cu + BPC-157 + TB-500
50 mg GHK-Cu · 10 mg TB-500 · 10 mg BPC-157 · 10 mg KPV
Per vial · verified against reference guide
Protocol card · research reference
- Starting dose
- ~1.8 mg total blend
- Studied range
- Per-vial ratio dependent
- Frequency
- Once daily
- Route
- Subcutaneous
- Cycle
- 4–8 weeks
Reconstitution reference
Storage: Powder: 2–8 °C, or −20 °C for longer storage. After mixing with BAC water: 2–8 °C, use within about 4 weeks.
KLOW
Once daily · units to draw on a U-100 syringe for a 1.8 mg dose.
| Vial | BAC water | mg/mL | Draw | Doses |
|---|---|---|---|---|
| 80 mg | 1 mL | 80 | 2.3 u | 44 |
| 80 mg | 2 mL | 40 | 4.5 u | 44 |
| 80 mg | 3 mL | 26.67 | 6.8 u | 44 |
Notes
- A common vial is 80 mg: GHK-Cu 50 / BPC-157 10 / TB-500 10 / KPV 10.
Calculate your vial
Draw to
—units
= — mL on a U-100 syringe
- Concentration
- —
- Per unit
- —
- Doses / vial
- —
Syringe
Where researchers source it
Listings are provided for reference — always verify the latest third-party COA before purchasing.
Medvinci Research
See siteFeatured supplier · third-party tested, COA published per batch
Supplier B
TBDPlaceholder — details coming soon
View productView COA
Supplier C
TBDPlaceholder — details coming soon
View productView COA